Joseph P. Fuhr, Jr., PhD, MA
Philadelphia, PA 19107
(215) 923-7583 fax
PhD, Temple University
MA, Temple University
BA, LaSalle University
Lecturer, Jefferson College of Population Health
Research & Practice Interests
Regulation Health Economics
Dr. Joseph Fuhr, Jr. is Professor of Economics at Widener University, Policy Advisor for The Heartland Institute, Senior Fellow with The American Consumer Institute and Ambassador for the Internet Innovation Alliance. He also teaches for the Jefferson College of Population Health. His primary research areas are antitrust, health economics, pharmacoeconomics, telecommunications and sports economics. In health care, he has written on hospital mergers, specialty hospitals, exclusive arrangements, health insurance, bundling and doctor's fees. In pharmacoeconomics, he has written on cost benefit analysis, biosimilars, comparative effectiveness research and predictive modeling. Dr. Fuhr received his PhD in Economics and MA in Economics, both from Temple University. He received his BA in Economics from LaSalle University.
Most Recent Peer-Reviewed Publications
- AMCP partnership forum: Biosimilars-ready, set, launch
- The economics of medicare accountable care organizations
- Product naming, pricing, and market uptake of biosimilars
- Drug shortages are costly to patients and to payers
- The health and economic effects of counterfeit drugs
- The economics of biosimilars
- Ask the experts: Future of the pharmaceutical industry
- Biosimilars and innovation: An analysis of the possibility of increased competition in biopharmaceuticals
- Biosimilars and follow-on biologics
- Why biosimilars will have a smaller competitive edge than generics
- Specialty hospitals: The economics and policy issues they pose
- Redefining health care: Creating value-based competition on results
- Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia
- Use of chromium picolinate and biotin in the management of type 2 diabetes: An economic analysis
- Diagnosing Crohn's disease: An economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures
- Failed hospital mergers.
- Winners, losers, and microsoft: Competition and antitrust in high technology
- Hospital mergers: the shift from federal antitrust enforcement to state regulation.
- Stee-rike four! What's wrong with the business of baseball?
- Rural hospital mergers, antitrust policy, and the Ukiah case